explore -WSS

explore

author：focus 2025-09-28 23:10:48 - browse：9192

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Doctors in states that ban abortion can still help patients

Wikipedia

WSS

Poland's lawmakers approve a divisive law on Russian influence

FDA seeks to regulate lab

Researchers use wearables data and AI to predict preterm birth risk

Listen: Who gets the credit for GLP

Covid vaccines: Private market messier than government rollout

After a drawn out lobbying fight, ARPA

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

Duchenne breakthrough therapy leaves behind pioneering families

Medicaid, Medicare dual

How one medical school became remarkably diverse

What AstraZeneca

New air purifier tech could be key to improving indoor air quality

WHO recommends dropping component of many flu vaccines

Jerome Adams on the need for new antivirals for Covid

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Anesthesiologist group: stop taking Ozempic before surgery

Philippine ferry was overloaded when it flipped over, leaving 27 dead, official says

focus

Health tech startups drop sharply from 2021 highs

Shingles, which affected Dianne Feinstein, is on the rise

Senator probes 340B programs at Cleveland Clinic, Bon Secours

Address the ethical violations that led to 'Three Identical Strangers'

Did you have Obamacare on your GOP debate bingo card?

Poland's lawmakers approve a divisive law on Russian influence

hotspot

Wikipedia

focus

focus